EMA Recommends Extending Indications for Decitabine / Cedazuridine By Ogkologos - May 29, 2026 104 0 Facebook Twitter Google+ Pinterest WhatsApp New indication concerns a combination with venetoclax for the treatment of adult patients with newly diagnosed AML Source RELATED ARTICLESMORE FROM AUTHOR ESMO Welcomes the WHO Global Status Report on Cancer with Key Recommendations for Equitable Cancer Care Lorlatinib Continues to Show Long-Term Benefit in Newly-Diagnosed Patients with Advanced ALK-positive NSCLC GLP-1 Receptor Agonist Use Associated with a Significantly Lower Short-Term Incidence of Obesity-Associated Cancers Among Obese Individuals Without Diabetes MOST POPULAR Post-Mastectomy Boutique Set to Close After 12 Years, As Owner Has... March 12, 2019 27-Year-Old Thought She Was Injured Falling Off A Horse, But Then... May 13, 2019 People who’ve had radiotherapy shape our new policy calls May 4, 2023 FDA Grants Accelerated Approval to Futibatinib for Cholangiocarcinoma October 6, 2022 Load more HOT NEWS Zucchini everywhere ESMO awards its first fellowship to support digital and computational pathology Leveraging Extensive Real-World Data to Systematically Identify Mutations that Predict the... Cancer in My Community: Addressing Regional Cancer Disparities in Peru
